Ascendis launches growth hormone Skytrofa in the US
![Photo: Kevin Grønnemann](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article11298514.ece/ALTERNATES/schema-16_9/ascendis.jpg)
A month and a half since securing the approval from the US Food and Drug Administration (FDA), Ascendis Pharma is ready to market the drug Skytrofa, which addresses the need of children suffering from growth hormone deficiency, informs the company in a press release.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Ascendis Pharma aims for USD 400m from share issue
For subscribers
Ascendis ready with clinical trial of another cancer drug
For subscribers